Suppr超能文献

储存在注射器和贮液器中的0.9%氯化钠注射液中芬太尼、布比卡因和可乐定混合物的微生物稳定性。

Microbiological stability of a fentanyl, bupivacaine and clonidine mixture in a 0.9% sodium chloride infusion stored in syringes and reservoirs.

作者信息

Jappinen A, Naaranlahti T, Kokki H, Ojanen T, Rasi A

机构信息

Department of Pharmacy, Central Finland Hospital, Jyvaskyla.

出版信息

Int J Pharm Compd. 2000 Jul-Aug;4(4):318-9.

Abstract

Combinations of extradural opioids and local anesthetic solutions are used in clinical practice, although little information exists on their microbiological or chemical stability. Currently there are no commercially available, prepacked, ready-to-use epidural mixtures of these medications and all mixtures must be prepared by the pharmacist. Epidural analgesic mixtures have been prepared on an as-needed basis. The aim of this study was to investigate the microbiological stability of a fentanyl, bupivacaine and clonidine mixture in a 0.9% sodium chloride infusion (without preservatives), prepared by the pharmacist in order to provide a basis for recommendations on the exchange of containgers (polypropylene syringes and polyvinylchloride [PVC] reservoirs). This mixture maintained microbiological stability for at least 28 days when prepared under aseptic conditions using a laminar air flow station, with a grade A environment and a B background, and using sterile clothes and equipment. During aseptic preparation in a grade A environment, less than 1 colony forming unit (CFU)/m3 and less than 3500 particles greater than 0.5 micrometers with no particle being greater than 5 micrometers, and in a grade B environment less than 10 CFU/m3 and less than 350,000 particles greater than 0.5 micrometers and less than 2,000 particles greater than 5 micrometers are allowed. Putatuive in situ antimicrobial activity of the drug mixture did not interfere with sterility testing. A pH difference was observed over time between the polypropylene syringes and the PVC reservoirs.

摘要

硬膜外阿片类药物与局部麻醉溶液的联合用药在临床实践中得到应用,尽管关于它们的微生物学或化学稳定性的信息较少。目前尚无市售的、预包装的、即用型的这些药物的硬膜外混合制剂,所有混合制剂都必须由药剂师配制。硬膜外镇痛混合制剂一直是按需配制。本研究的目的是调查药剂师配制的芬太尼、布比卡因和可乐定在0.9%氯化钠注射液(无防腐剂)中的混合液的微生物稳定性,以便为关于容器(聚丙烯注射器和聚氯乙烯[PVC]储液器)更换的建议提供依据。当在使用A级环境和B级背景的层流空气流动工作站、无菌衣物和设备的无菌条件下配制时,这种混合液至少28天保持微生物稳定性。在A级环境中进行无菌配制时,允许菌落形成单位(CFU)/立方米少于1个,大于0.5微米的颗粒少于3500个且无颗粒大于5微米;在B级环境中,允许CFU/立方米少于10个,大于0.5微米的颗粒少于350,000个且大于5微米的颗粒少于2,000个。药物混合液的假定原位抗菌活性不干扰无菌检测。随着时间的推移,观察到聚丙烯注射器和PVC储液器之间存在pH差异。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验